Deviation investigation guidelines in the pharmaceutical industry
GMPSOP
JUNE 28, 2024
Additional documents included each month. In the five years between 2019 and 2023, the FDA issued the following warning letters, closely related to ineffective deviation investigation. In 2019 and 2020, warning letters were issued for “Adulterated Food and Supplements” at 36% and 33%, respectively. Checkout sample preview s.
59 
Let's personalize your content